Published in Women's Health Weekly, June 17th, 2004
Previous studies have pointed to chromosomal regions at 9q22-31 and 9q32-34 as possibly important in the development of ovarian cancer. J. Byrom and colleagues at Keele University, North Staffordshire, U.K., studied "LOH at 9q22-31 in 85 patients with epithelial ovarian cancer, 15 with non-epithelial tumors, and 16 with benign disease."
"Varying patterns of LOH were observed across the markers used between different tumors, the most common (71%) being interstitial discontinuous losses," the team reported. "LOH was frequent,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.